錯誤 --06-30 2025 Q1 0001748137 0001748137 2024-07-01 2024-09-30 0001748137 NEOV:每股普通股面值0.001美元會員 2024-07-01 2024-09-30 0001748137 NEOV:認股權證,每份認股權證可行使一份普通股會員 2024-07-01 2024-09-30 0001748137 2024-11-08 0001748137 2024-09-30 0001748137 2024-06-30 0001748137 2023-07-01 2023-09-30 0001748137 US-GAAP:普通股成員 2024-06-30 0001748137 美元指數: 應付股本會員 2024-06-30 0001748137 us-gaap:留存收益成員 2024-06-30 0001748137 US-GAAP:普通股成員 2023-06-30 0001748137 美元指數: 應付股本會員 2023-06-30 0001748137 us-gaap:留存收益成員 2023-06-30 0001748137 2023-06-30 0001748137 US-GAAP:普通股成員 2024-07-01 2024-09-30 0001748137 美元指數: 應付股本會員 2024-07-01 2024-09-30 0001748137 us-gaap:留存收益成員 2024-07-01 2024-09-30 0001748137 US-GAAP:普通股成員 2023-07-01 2023-09-30 0001748137 美元指數: 應付股本會員 2023-07-01 2023-09-30 0001748137 us-gaap:留存收益成員 2023-07-01 2023-09-30 0001748137 US-GAAP:普通股成員 2024-09-30 0001748137 美元指數: 應付股本會員 2024-09-30 0001748137 us-gaap:留存收益成員 2024-09-30 0001748137 US-GAAP:普通股成員 2023-09-30 0001748137 美元指數: 應付股本會員 2023-09-30 0001748137 us-gaap:留存收益成員 2023-09-30 0001748137 2023-09-30 0001748137 2023-04-30 0001748137 美國通用會計準則:淨銷售收入會員 us-gaap:客戶集中度風險成員 NEOV:一家成員經紀人 2024-07-01 2024-09-30 0001748137 美國通用會計準則:淨銷售收入會員 us-gaap:客戶集中度風險成員 NEOV: 二號成員 2024-07-01 2024-09-30 0001748137 美國通用會計準則:淨銷售收入會員 us-gaap:客戶集中度風險成員 NEOV: 三號成員 2024-07-01 2024-09-30 0001748137 us-gaap:AccountsReceivableMember us-gaap:客戶集中度風險成員 NEOV:三家經銷商成員 2024-07-01 2024-09-30 0001748137 美國通用會計準則:淨銷售收入會員 us-gaap:客戶集中度風險成員 NEOV:第一家經銷商成員 2023-07-01 2023-09-30 0001748137 美國通用會計準則:淨銷售收入會員 us-gaap:客戶集中度風險成員 NEOV:第二家經銷商成員 2023-07-01 2023-09-30 0001748137 NEOV:受限制股票單位成員 NEOV:高級管理人員和另一名僱員成員 2024-07-01 2024-09-30 0001748137 NEOV:認股權證成員 NEOV:投資者成員 2024-07-01 2024-09-30 0001748137 NEOV:認股權證成員 NEOV:包銷商成員 2024-07-01 2024-09-30 0001748137 NEOV:受限制股票單位成員 NEOV:一名高級管理人員成員 2024-07-01 2024-09-30 0001748137 US-GAAP:普通股成員 NEOV: 董事及其他顧問成員 2024-07-01 2024-09-30 0001748137 2024-09-03 0001748137 2024-09-01 2024-09-03 0001748137 NEOV: 承銷公開發行成員 2022-08-01 2022-08-31 0001748137 NEOV: 承銷公開發行成員 NEOV: 單位成員 2022-08-01 2022-08-31 0001748137 NEOV: 承銷公開發行成員 NEOV: 承銷方成員 2022-08-01 2022-08-31 0001748137 NEOV: 承銷公開發行成員 NEOV: 承銷方成員 2022-08-31 0001748137 NEOV:包銷的公開發行會員 NEOV:可轉換票據2018會員 2022-08-01 2022-08-31 0001748137 NEOV:包銷的公開發行會員 NEOV:可轉換票據2021會員 2022-08-01 2022-08-31 0001748137 srt:ChiefExecutiveOfficerMember 美國通用會計原則限制性股票單位累計成員 2024-04-01 2024-04-30 0001748137 NEOV:前首席執行官會員 美國通用會計原則限制性股票單位累計成員 NEOV:里程碑1會員 2022-01-01 2022-12-31 0001748137 srt:首席財務官成員 美國通用會計原則限制性股票單位累計成員 NEOV:里程碑1會員 2022-01-01 2022-12-31 0001748137 srt:首席財務官成員 美國通用會計原則限制性股票單位累計成員 NEOV:里程碑2會員 2024-01-01 2024-12-31 0001748137 美國通用會計原則限制性股票單位累計成員 NEOV:三位執行官和一名非執行成員 2024-07-01 2024-09-30 0001748137 美國通用會計原則限制性股票單位累計成員 NEOV:三名執行官和一名非執行成員 2023-07-01 2023-09-30 0001748137 NEOV:兩名董事成員 2024-09-30 0001748137 NEOV:RS美元成員的攤銷價值 2024-07-01 2024-09-30 0001748137 NEOV:補償計劃成員的攤銷價值 2024-07-01 2024-09-30 0001748137 US-GAAP:普通股成員 NEOV:兩名受讓人成員 2024-07-01 2024-09-30 0001748137 NEOV:美元指數的RS會員攤銷值 2023-07-01 2023-09-30 0001748137 NEOV:補償計劃會員的攤銷價值 2023-07-01 2023-09-30 0001748137 NEOV:2019年股票計劃會員 2019-02-28 0001748137 NEOV:2019年股票計劃會員 2019-03-01 2024-09-30 0001748137 NEOV:2019年股票計劃會員 NEOV:三名執行長和非執行人員會員 美國通用會計原則限制性股票單位累計成員 2019-03-01 2024-09-30 0001748137 NEOV:2019年股票計劃會員 NEOV:三名獨立董事成員 美國通用會計原則限制性股票單位累計成員 2019-03-01 2024-09-30 0001748137 NEOV:2019年股票計劃成員 NEOV:幾家批發經銷商成員 美國通用會計原則限制性股票單位累計成員 2019-03-01 2024-09-30 0001748137 NEOV:認股權證成員 2024-06-30 0001748137 NEOV:認股權證成員 2024-07-01 2024-09-30 0001748137 NEOV:認股權證成員 2024-09-30 iso4217:USD xbrli:股份 iso4217:USD xbrli:股份 xbrli:純形

目錄

 

美國

證券交易委員會

華盛頓特區20549

 

表格 10-Q

 

《1934年證券交易法》第13或15(d)條之季度報告

截止至本季度結束 2024年9月30日

 

 

根據1934年證券交易法第13或第15(d)條的過渡報告

過渡期從______________到______________

 

委員會檔案編號: 001-41447

 

新奧沃爾塔, 公司

(依憑章程所載的完整登記名稱)

 

內華達州   82-5299263

(成立的州或其他地區)

(公司註冊地)

 

(國稅局雇主識別號碼)

識別號碼)

 

Danielson Street 13651號, 套房A

Poway, 加州 CA

  92064

(主要地址

(執行辦公室地址)

  (郵遞區號)

 

申報人的電話號碼,包括區號: (800) 364-5464

 

根據法案第12(b)條註冊的證券:

 

每種類別的名稱 交易標的(S) 每個註冊交易所的名稱
每股普通股,每股面值$0.001 NEOV 納斯達克股票市場有限公司
每一個認股權證均可行使購買一股普通股 NEOVW 納斯達克股票市場有限公司

 

根據法案第12(g)條的規定註冊的證券:

 

請勾選是否在過去12個月內,申報人已根據1934年證券交易法第13條或第15(d)條的要求提交了所有應提交的報告(或在申報人被要求提交此類報告的較短期間內),並且(2)過去90天依然受到此類申報要求。 ☒    否: ☐

 

請以勾選方式指出,是否在過去12個月內(或對於需提交此類檔案的較短期間),申報人已按照Regulation S-t(本章節§232.405)第405條規定要求提交每份互動資料檔案。 : ☒    不: ☐

 

請用勾選標記表示公司是否為大型加速註冊人、加速註冊人、非加速註冊人、較小的報告公司或新興成長公司。 請參閱「大型加速遞交者,” “加速遞交者,” “較小的報告 公司」與「Controlled」有相關的含義。新興成長公司在《交易所法》第1202條中,請參閱“”的定義。

 

大型加速提交人 ☐   加速提交人 ☐
非加速歸檔人   較小的報告公司
   

新興成長型公司

 

如果是新興成長性企業,請勾選是否選擇使用延長的過渡期以符合任何新的或修訂的財務會計準則,根據《交易法》第13(a)節的規定。

 

請用複選標記指示註冊人是否爲殼公司(如《證券交易法》第120億.2條定義的那樣)是 ☐No

 

截至2024年11月8日,每股面值為$0.001的普通股流通股份數為 33,361,711 股份.

 

   

 

 

NEOVOLTA, INC.

表格10-Q

2024年9月30日

 

指数

 

 

  頁面
   
關於前瞻性聲明的注意事項 3
   
第一部分. 財務資訊 4
   
項目1. 基本報表 4
2024年9月30日及2024年6月30日的資產負債表(未經審核) 4

截至2024年9月30日及2024年2023年三個月營運報表(未經審核)

5

截至2024年9月30日及2023年三個月股東權益報表(未經審核)

6

截至2024年9月30日及2023年三個月現金流量表(未經審核)

7
基本財務報表附註(未經審計) 8
第二項。管理層對財務狀況和經營業績的討論和分析 14
項目3.有關市場風險的定量和質量披露 17
第四項。控制和程序 17
   

第二部分。其他資訊

18
   
項目1. 法律訴訟 18
第1A項。風險因素 18
第 2 項。未註冊的股票發行和款項使用 18
第三項。優先證券拖欠。 18
第4項。礦山安全披露。 18
項目5。其他信息。 18
項目6. 附件 19
簽名 20

 

 

 

 

 

 

 2 

 

 

關於前瞻性聲明的注意事項

 

本季度Form上的季度報告 10-Q(以下簡稱“報告”)包含根據1995年《私人證券訴訟改革法案》的前瞻性陳述。我們在“風險因素” “財務狀況和經營結果的管理層討論及分析” 和本報告的其他部分中發表前瞻性聲明。在某些情況下,您可以通過以下詞語識別前瞻性聲明:“預計” “相信” “繼續,” “可能,” “估計,” “期望” “打算” “可能,” “進行中的,” “計劃” “潛力,” “預測,” “或類似表述的目的是確定” “應該”或這些術語的否定或其他類似術語,儘管並非所有前瞻性陳述都含有這些詞語。前瞻性陳述並非對未來業績或結果的擔保,並不一定準確地表示或暗示出所述的業績或結果將在何時或在何時間實現。前瞻性陳述基於在發表時可獲得的信息,並涉及已知和未知的風險、不確定因素和其他因素,這些因素可能導致我們的業績、活動水平、表現或成就與本報告中前瞻性陳述所表達或暗示的信息有很大不同。

 

您應該閱讀在本報告中所描述並被引用的事項。風險因素以及在本報告中提出的其他注意事項,應視爲適用於本報告中所有其他相關的前瞻性聲明。我們不能保證本報告中的前瞻性聲明會被證明準確,因此鼓勵潛在投資者不要過度依賴前瞻性聲明。

 

所有前瞻性聲明僅代表此季度報告提交日期。您不應該把前瞻性聲明作爲未來事件的預測依據。讀者不應過分依賴這些前瞻性聲明。儘管我們認爲本報告中我們所作前瞻性聲明所反映或暗示的計劃、意圖和預期是合理的,但我們不能保證這些計劃、意圖或預期會實現。我們披露了可能導致我們實際結果與我們期望有重大差異的重要因素,在本季度報告和截至2024年6月30日提交給SEC並於2024年9月27日提交的年度報告的「」以及其他地方。這些警示性聲明限定我們或代表我們行事的任何人所歸因的所有前瞻性聲明。我們不承擔任何義務更新或公開修訂任何前瞻性聲明,除非法律要求,包括美國的證券法和SEC的規則和規定。風險因素” 和 “管理層對財務狀況和業務運營成果的討論和分析” 和本季度報告以及2024年6月30日提交給SEC並於2024年9月27日提交的年度報告的處,除了遵守美國證券法和SEC的規章,我們不對任何前瞻性聲明進行更新或修訂的公開承諾。

 

 

 

 

 

 

 

 

 

 3 

 

 

第I部分。財務信息

 

項目1。 基本報表

 

NEOVOLTA, INC.

資產負債表

(未經審計)


   9月30日,   6月30日, 
   2024   2024 
資產          
流動資產:          
現金及現金等價物  $393,396   $986,427 
2,687,823    1,950,684    1,805,980 
114,467    1,767,624    1,787,308 
預付保險和其他流動資產   38,406    76,815 
總流動資產   4,150,110    4,656,530 
           
資產總額  $4,150,110   $4,656,530 
           
負債和股東權益          
流動負債:          
應付賬款  $216,333   $5,316 
應計負債   37,442    55,784 
流動負債合計   253,775    61,100 
           
承諾和或因應事項(注4)        
           
股東權益:          
普通股,每股面值爲 $0.0001;0.001每股面值,100,000,000 33,245,86733,236,091 持股數分別爲74,329,545和73,872,679股    33,246    33,236 
額外實收資本   25,570,121    25,304,732 
累積赤字   (21,707,032)   (20,742,538)
股東權益合計   3,896,335    4,595,430 
           
負債和股東權益合計  $4,150,110   $4,656,530 

 

 

請參見未經審計的財務報表附註。

 

 

 

 

 

 

 

 4 

 

 

NEOVOLTA, INC.

損益表

(未經審計)

 

               
   三個月已結束 
   九月三十日 
   2024   2023 
         
與客戶簽訂合同的收入  $590,236   $764,130 
售出商品的成本   497,389    642,958 
毛利潤   92,847    121,172 
           
運營費用:          
一般和行政   1,050,119    555,160 
研究和開發   8,617     
運營費用總額   1,058,736    555,160 
           
運營損失   (965,889)   (433,988)
           
其他收入:          
利息收入   1,395    5,273 
其他收入總額   1,395    5,273 
           
淨虧損  $(964,494)  $(428,715)
           
加權平均已發行股票——基本股和攤薄後股票   33,244,061    33,155,127 
           
每股淨虧損——基本虧損和攤薄後虧損  $(0.03)  $(0.01)

 

 

請參見未經審計的財務報表附註。

 

 

 

 

 

 

 

 5 

 

 

NEOVOLTA, INC.

股東權益變動表

2024年和2023年截至9月30日的三個月

(未經審計)

 

           額外       總計 
   普通股   付費   累積   股東 
   股票   金額   資本   赤字   股權 
                     
截至 2024 年 6 月 30 日的餘額   33,236,091   $33,236   $25,304,732   $(20,742,538)  $4,595,430 
                          
股票補償費用   9,776    10    265,389        265,399 
                          
淨虧損               (964,494)   (964,494)
                          
截至 2024 年 9 月 30 日的餘額   33,245,867   $33,246   $25,570,121   $(21,707,032)  $3,896,335 

 

 

           額外       總計 
   普通股   付費   累積   股東 
   股票   金額   資本   赤字   股權 
                     
截至 2023 年 6 月 30 日的餘額   33,155,127   $33,155   $24,872,446   $(18,439,228)  $6,466,373 
                          
股票補償費用           84,717        84,717 
                          
淨虧損               (428,715)   (428,715)
                          
截至 2023 年 9 月 30 日的餘額   33,155,127   $33,155   $24,957,163   $(18,867,943)  $6,122,375 

 

 

請參見未經審計的財務報表附註。

 

 

 

 

 

 6 

 

 

NEOVOLTA, INC.

現金流量表

(未經審計)

 

         
   三個月的結束 
   9月30日, 
   2024   2023 
經營活動現金流量:          
淨損失  $(964,494)  $(428,715)
用於調節淨損失與經營活動現金流量的項目:          
股票報酬支出   265,399    84,717 
預計信貸損失準備/壞賬費用   85,250    110,000 
流動資產和負債的變動          
應收賬款   (229,954)   (359,129)
庫存   19,684    353,349 
預付保險和其他流動資產   38,409    50,803 
應付賬款   211,017     
應計費用   (18,342)   9,886 
經營活動產生的淨現金流量   (593,031)   (179,089)
           
現金及現金等價物淨減少   (593,031)   (179,089)
           
期初現金及現金等價物餘額   986,427    2,002,789 
           
期末現金及現金等價物  $393,396   $1,823,700 
           
現金流補充資料披露          
支付的利息現金  $   $ 
支付的所得稅費用  $   $ 

 

 

請參見未經審計的財務報表附註。

 

 

 

 

 

 

 

 

 

 

 7 

 

 

NEOVOLTA, INC.

財務報表說明

(未經審計)

 

 

(1) 業務和重要會計政策概述

 

業務描述NeoVolta公司(「我們」或「公司」)是一家成立於2018年3月5日的內華達州公司。該公司是一家能源存儲系統(ESS)的設計師、銷售商和製造商,可以通過電池和逆變器存儲和使用能源,用於住宅和商業場所。該公司通過批發客戶銷售其專有的ESS裝置,主要在加利福尼亞州,以及其他不斷擴大的州份進行銷售。2022年8月,公司完成了其股權證券的承銷公開發行,該發行使其普通股和認股權證在國家交易所上市(見註釋3)。

 

中期財務報告 公司已按照美國通用會計準則未經審計地編制了附表基本報表,根據證券交易委員會("SEC")的規則和法規,用於中期財務信息。據管理層意見,這些基本報表包括所有必要的調整,僅包括正常週期性調整,以公允陳述2024年9月30日公司資產負債狀況,截至2024年9月30日和2023年的三個月內運營成果,截至2024年9月30日和2023年的三個月內股東權益變動,以及截至2024年9月30日和2023年的三個月內現金流量。截至2024年6月30日的資產負債表來源於由獨立的註冊會計師事務所對公司於2024年6月30日的財務報表進行審計,但不包含所有完整年度財務報表所需的信息和附註。中期期間的經營結果未必能反映出全年的預期結果。這些基本報表應與我們的年度10-K報告結合閱讀,該報告截至2024年6月30日年度,已於2024年9月27日向SEC提交。

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $143,396.

 

庫存 庫存由從亞洲供應商購買並交付至公司辦公室附近位置的電池和逆變器組成,用於組裝能源存儲系統單元。此外,我們在2023年4月從前合同製造商處大宗購買了包括組裝元件的原材料,總金額爲$1.4百萬庫存按照成本或淨現金實現價值較低者計量,成本採用先進先出(FIFO)法確定。公司定期審查庫存項目的價值,並根據市場條件、庫存週轉率和當前庫存水平的評估,記錄減值準備,以將庫存的賬面價值減少至成本或淨現金實現價值較低者。庫存減值影響記入營業成本。以下表格顯示了截至2024年9月30日和2024年6月30日的庫存(減去組裝元件$90,000 的過時準備)組成:

 

存貨清單表  9月30日,
2024
   6月30日,
2024
 
         
原材料包括組裝部件、電池和逆變器  $1,339,559   $1,076,479 
進行中的工作       89,386 
成品   428,065    621,443 
           
總計  $1,767,624   $1,787,308 

 

 

 8 

 

 

收入確認公司按照會計準則更新(「ASU」) 2014-09《與客戶簽訂的合同收入》(Topic 606)確認營業收入。當承諾商品的控制權轉移給客戶,且金額反映了公司預期在交換商品或服務時應該獲得的衡量值時,將確認營業收入。營業收入根據以下五個步驟的模型確認:

 

·識別與客戶簽訂的合同
·確定合同中的履行承諾。
·確定交易價格。
·對合同中的履行承諾的交易價格進行分配。
·在公司履行績效義務的時候或據此擁有資格以及類似財務原則性的規定中,確認收入

 

公司通過與客戶簽訂的合同產生營業收入,主要由加利福尼亞州的一家相對較少的批發商和安裝商組成。在2024年9月30日結束的三個月中,三家這樣的經銷商大約代表了公司營業收入的 37%, 26%和13其營收中約%由三家經銷商代表,然而,在此期間,沒有其他經銷商貢獻的營業收入超過公司營收的10%。另外三家經銷商代表了截至2024年9月30日公司應收賬款的約 82的總額約爲%。兩家這樣的經銷商在截至2024年9月30日結束的三個月中代表了公司營業收入的約 47% 和 19,由於公司所有的營業收入目前都來自類似產品的銷售,因此未提供有關截至2024年9月30日以及2023年此期間的營收信息的進一步細分。

 

預期信用虧損準備金 - 公司在預計會發生損失時,會確認一筆預期信用虧損準備金,以便在確認客戶帳戶時進行處理。截至2024年9月30日和2024年6月30日,我們的預期信用虧損準備金爲$1,020,000 和$1,030,000,分別爲。

 

股票薪酬費用 - 員工和非員工基於股票支付的補償金在發放日期按照獎勵的公允價值計量,並按照必要服務期間分期確認爲費用。

 

每股普通股虧損 — 每股普通股的基本虧損是通過普通股股東可獲得的淨虧損除以加權平均數計算得出的 在此期間流通的普通股。普通股每股攤薄虧損使用普通股的加權平均數確定 經普通股等價物的稀釋效應調整後,該期間未清償債務。在報告損失的時期, 已發行普通股的加權平均數不包括普通股等價物,因爲它們的納入將具有反稀釋作用。 截至2024年9月30日,該公司的已發行普通股等價物總額爲 2,693,775 股份如下:(i) 1,348,181 與2024年4月授予一名高級管理人員和另一名員工的限制性股票單位相關的股份;(ii) 1,121,250 與認股權證相關的股票 在2022年8月完成的公開發行中向投資者發行;(iii) 58,500 與向承銷商發行的認股權證相關的股票 在同一次發行中;(iv) 50,000 與2022年3月授予高級管理人員的限制性股票單位相關的股份;以及 (v) 115,844 股份 可發行給董事和其他顧問(見附註3和5)。

 

研發費用 研發成本-研發成本發生時應當確認支出。

 

使用估計 管理層在編制這些基本報表時,根據美國通行的會計準則進行了大量估計和假設。實際結果可能與這些估計有所不同。

 

最近的會計聲明 - 不時會有新的會計準則由財務會計準則委員會(「FASB」)或其他標準制定機構發佈,並在規定的生效日期採納。除非另有討論,尚未生效的最近發佈的和將來可能生效的準則對公司的財務狀況或經營業績的影響在採納後不會對公司產生重大影響。公司已考慮了所有其他最近發佈的會計準則,並不認爲採納這些準則將對其基本報表產生重大影響。

 

 

 

 9 

 

 

流動性 ——這些基本報表是根據持續經營的假設進行編制的,即公司將繼續在正常業務過程中實現資產並清償其責任。公司作爲持續經營的繼續存在,取決於公司獲得必要的債務和股本融資以繼續經營,並實現盈利操作。

 

如基本報表中披露的,請注意2,我們最近與融資機構達成協議,已獲得一筆500萬美元的信貸額度,以滿足任何近期的融資需求。因此,我們相信我們將有足夠的財務資源可供使用,以便至少在這些財務報表發佈之日起的未來12個月內經營我們的業務。

 

(2) 應付票據

 

在2024年9月3日,我們與一家新成立的融資實體達成協議,獲得了一筆高達$的信貸額度5,000,000。根據該協議,我們將需要向貸款人支付累計利息,利率爲 16%, 對我們所做的任何未償還借款按月計算,本金和任何未支付的累計利息到期日爲2026年9月3日 。爲了擔保此類借款,我們已向貸款人抵押了所有資產。作爲從貸款人處獲得此信貸額度的條件,我們同意,在任何借款仍未償還的情況下,不向公司的Form S-3(文件號333-280400)發行任何證券,而不經貸款人同意。截至2024年9月30日,我們根據此信貸協議已進行了筆借款(見附註5)。 no,我們支付了資產所有權利作爲賒賬函入住、任何剩餘未支付的應計利息及本金在借款截止日9/3/2026。爲了確保這些貸款,我們將全部資產轉讓給貸款人。作爲從貸款人處獲得此信貸額度的一個條件,我們同意,只要有未償還的借款,不發行公司Form S-3(檔案號333-280400)的證券需經貸款人同意。截至2024年9月30日,我們根據該信貸協議已有5筆借款(見注5)。

 

(3) 股權

 

普通股 在2022年8月,公司完成了其股權證券以單位形式的包銷公開發行 每個單位包括一份普通股和一份認股權證(每份「認股權證」及統稱「認股權證」),用於以每份4.00美元的行權價購買一份普通股。 組成單位的普通股和認股權證在發行結束時立即拆分,現在分別在納斯達克資本市場上獨立上市。每份認股權證自發行日起可行使,將在發行日期後五年到期。

 

在以下公開發行中,總共 1,121,250 份單位,在包括承銷商超額配售選擇權的情況下,以每單位的發行價4.00美元向公衆出售。發行的總收益爲$4,485,000 而扣除承銷折扣和其他發行成本後的淨收益約爲$3,780,000。公司還向承銷商授予了有權購買的不可轉讓權證 58,500,附有認股權證以$每股行使價購買普通股。4.40 股,期限爲五年。

 

與公開發行同時,所有持有公司2018年可轉股票據,總額爲$59,251,包括應計利息,在規定的轉換率下將其債務轉換爲總共 9,404,867 股普通股,所有持有公司2021年可轉股票據,總額爲$1,120,035,包括應計利息,自動將其債務轉換爲總共 267,000股普通股,根據規定的轉換率。

 

權證 ——對投資者和承銷商發行的普通股的權證總計 1,179,750 股份,自首次發行之日起至首次發行之後五年的任何時間內行使,或 公司記錄了$。權證可以在到期日之前或之日支付行使價格後行使。根據權證協議的條款,我們必須盡最大努力維持與可行權證的共同股有關的註冊聲明和現行發售意向書的有效性,直至權證到期爲止。如果我們未能維持與可行權證的共同股有關的註冊聲明和現行發售意向書的有效性,持有權證的持有人有權行使權證,僅限於權證中規定的無現金行使特性,直至有效註冊聲明和現行發售意向書出現爲止。

 

 

 

 

 10 

 

 

以下表格展示了截至2024年9月30日的三個月內公司權證的活動情況:

 

認股權活動進度表  數量   加權平均   加權平均   總計 
      行權   剩餘   截至2023年7月29日的餘額 
   股份   價格   期限(年)   價值 
2024年6月30日的未結餘額   1,179,750   $4.02           
權證發行                  
權證行使/放棄                  
截至2024年9月30日應收款項   1,179,750   $4.02    2.8   $ 
                     
2024年9月30日可行使   1,179,750   $4.02    2.8   $ 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In April 2024, we entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, our new CEO received an initial equity grant equal to 1,280,000 restricted stock units (“RSU’s”), with a grant date value of $2,854,000, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s on each anniversary in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each. However, no such additional grants have been made as of September 30, 2024.

 

In February 2022, we entered into a new employment agreement with our then CEO, effective April 1, 2022. As noted above, we engaged a new CEO effective April 29, 2024, replacing our former CEO who remains as Chairman of the Board and chief technology officer. Pursuant to the agreement, we issued our former CEO an RSU award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 had been achieved, however, Milestone 2 had not been achieved and was no longer achievable. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to our former CEO as of January 1, 2023.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO at a later date.

 

Based upon our assessment of the probability of our three executive officers noted above, plus a non-executive recipient of another RSU award issued in June 2024, ultimately achieving any applicable milestones specified under the RSU awards indicated above, we have calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the three months ended September 30, 2024 and 2023 in the amounts of $221,524 and $40,842, respectively

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of September 30, 2024, we booked an accrual of $48,750 of compensation expense (of which $43,875 will be settled through the issuance of shares) for our three independent directors under this plan.

 

 

 

 11 

 

 

In the three months ended September 30, 2024, we recognized total non-cash stock compensation expense of $265,399 as follows: (i) $221,524 for the amortized value of the RSUs granted to our chief executive officer, as previously described, plus a non-executive recipient of another RSU award granted in June 2024; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were a total of 9,776 shares of our common stock that were issued to two grantees in the three months ended September 30, 2024, which were previously expensed in the year ended June 30, 2024.

 

In the three months ended September 30, 2023, we recognized total non-cash stock compensation expense of $84,717 as follows: (i) $40,842 for the amortized value of the RSUs granted to our two executive officers, as previously described; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were no shares of common stock that were issued to any grantees in the three months ended September 30, 2023.

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of September 30, 2024, we have made total awards of 1,992,623 shares under the Plan as follows: (i) 1,798,181 shares for the RSUs granted to our three executive officers and a non-executive recipient, as noted above; (ii) 153,808 shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 40,634 shares granted to several wholesale dealers under an incentive sales program.

 

(4) Commitments and Contingencies

 

Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, Leases. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.

 

As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums, as determined annually on a calendar year basis.

 

We are dependent on our two main component vendors for our suppliers of batteries, inverters and other raw materials and the inability of these single-source suppliers to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us, or our inability to efficiently manage these components, could have a material adverse effect on our financial condition and operating results.

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 

 

 

 12 

 

 

 

(5) Subsequent Events

 

In October 2024, we issued a total of 115,844 shares of our common stock to certain Board members and various advisors, pursuant to annual contracts for their services. Included in this issuance were 98,844 shares attributable to our three independent directors and 17,000 shares attributable to various other advisors. We issued all of these shares to the recipients as consideration for their services rendered in the year ended June 30, 2024, and we have recognized the underlying expense for such services in the year ended June 30, 2024.

 

In October 2024, we also made a short-term loan in the amount of $250,000 to a new customer which has a government-backed contract to install a large number of our units in Puerto Rico over a two year period. The purpose of the loan was to provide short term working capital to the customer in conjunction with the startup of the contract in Puerto Rico. This loan was largely funded by making a partial draw down on our recently obtained line of credit (see Note 2). Interest on the loan will accrue at the rate of 3% per annum on the unpaid balance, beginning January 1, 2025, and will increase to a rate of 6% per annum on the unpaid balance, beginning July 1, 2025, and will be payable monthly, beginning February 1, 2025. The principal and any unpaid interest will be payable in one year from the date of the loan.

 

 

 

 

 

 

 

 

 

 

 

 13 

 

 

ITEM 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Introduction

 

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2024, filed with the Securities and Exchange Commission on September 27, 2024 (the “Annual Report”).

 

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited financial statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.

 

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “NEOV”, refer specifically to NeoVolta, Inc.

 

In addition, unless the context otherwise requires and for the purposes of this Report only:

 

·“Exchange Act” refers to the Securities Exchange Act of 1934, as amended; 

 

·“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and 

 

·“Securities Act” refers to the Securities Act of 1933, as amended. 

 

Overview

 

We are a designer, manufacturer, and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14, NV14-K, and NV-24, which can store and use energy via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers, and other commercial opportunities. Because we are purely dedicated to energy solar systems, virtually all our current resources and efforts go into further developing our flagship NV14, NV14-K, and NV-24 products, while focusing on specific industry needs for our next generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself as a major player in the energy storage market.

 

In May 2019, we completed a public offering of 3,500,000 shares of our common stock at an offering price of $1.00 per share for gross proceeds of $3.5 million pursuant to Regulation A of the Securities Act. We used the proceeds of the offering to ramp up production, marketing, and sales of our NV14 product line. In that regard, we have used the proceeds from the offering to fund the marketing, production and distribution of our products, which commenced in July 2019 through a group of wholesale customers in California, as well as to provide additional working capital for other corporate purposes. We have expanded to include one wholesale distribution customer in Nevada. As of the current date, we have had successful installations of our products in the additional States of Arizona, Utah, Colorado, Wyoming, Texas, Oklahoma, Missouri, Tennessee, Alabama, Georgia, Florida, and Puerto Rico.

 

 

 

 14 

 

 

As further discussed below under “Liquidity and Capital Resources,” we completed an underwritten public offering of our equity securities in the form of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

 

On April 14, 2023, California implemented Net Energy Metering 3 (NEM3) for subsequent new solar installations. NEM3 reduces the amount of NEM credit for each kilowatt (KW) of solar power sent to the utility from a rate of approximately $0.20 per KW to $0.09 per KW (each Utility varies). NEM3 effectively increases the average solar Return of Investment (ROI) from 5-6 years to 10-12 years (each Utility varies). Effectively, the Company believes that solar installation in California currently makes little financial sense without also including a battery system. Installing NeoVolta nets a ROI of 4-6 years. NEM3 reduced our sales from December 2022 until very recently   as solar installers worked off their permitted NEM2 installs. We expect our sales to ultimately increase going forward.

 

Results of Operations

 

The following discussion reflects the Company’s revenues and expenses for the three month periods ended September 30, 2024 and 2023, as reported in our financial statements included in Item 1.

 

Revenues - Revenues from contracts with customers for the three months ended September 30, 2024 were $590,236 compared to $764,130 for the three months ended September 30, 2023. Such decrease was primarily due to the impact of various macroeconomic factors, such as relatively high interest rates, and regulatory factors, such as utility regulations in the State of California that we believe may have temporarily caused an economic disadvantage for residential utility customers to acquire our energy storage systems not only prior to the April 2023 effective date of those regulations, but also subsequently, as certain implications of them because better known in the marketplace.   

 

Cost of Goods Sold - Cost of goods sold for the three months ended September 30, 2024 were $497,389 compared to $642,958 for the three months ended September 30, 2023. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 16% in both periods.

 

General and Administrative Expense - General and administrative expenses for the three months ended September 30, 2024 were $1,050,119 compared to $555,160 for the three months ended September 30, 2023. Such increase was mainly due to our engagement of a new chief executive officer, who was engaged at an annual salary of $350,000 and also received a 4 year amortizing equity award of $2,854,000, as well as several other employees since April 2024. The addition of these personnel resulted in a higher level of both cash compensation expense and other associated expenses, such as marketing and travel, as well as non-cash stock compensation expenses related to the Company’s equity incentive programs.

 

Research and Development Expense - Research and development expenses for the three months ended September 30, 2024 were $8,617 compared to zero for the three months ended September 30, 2023. Such fluctuation was largely due to timing differences in the level of the Company’s recent product development efforts.

 

Other Income and Expense - Interest income for the three months ended September 30, 2024 was $1,395 compared to $5,273 for the three months ended September 30, 2023. This decrease was due to the Company’s lower level of investable cash in the three months ended September 30, 2024.

 

Net Loss - Net loss for the three months ended September 30, 2024 was $964,494 compared to $428,715 for the three months ended September 30, 2023, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

 

 

 

 15 

 

 

Liquidity and Capital Resources

 

Operating activities. Net cash used in operating activities in the three months ended September 30, 2024 was $593,031 compared to $179,089 in the three months ended September 30, 2023. This increase was largely due to the current period increase in our comparative net loss, largely due to the decline in our gross profit and the increase in our other cash operating expenses. The fluctuations in our working capital components had only a de minimis impact on net operating cash flow on a comparative basis.

 

Financing activities. As indicated in Note 2, we entered into an agreement with a newly formed financing entity in September 2024 whereby we obtained a line of credit for borrowings of up to $5,000,000. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity in September 2026. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As of September 30, 2024, we had made no borrowings under this credit agreement.

 

As of September 30, 2024, we had a cash balance of approximately $0.4 million and net working capital of approximately $3.9 million. Currently, we are not generating a break-even level of net operating cash flow from our net sales. However, we anticipate that demand for our products will ultimately increase over time and that, in conjunction with our recently obtained line of credit noted above, we will have sufficient cash to operate for at least the next 12 months.

 

Assembly Inventory Purchase

 

In April 2023, we made a bulk purchase of raw materials inventory from our contract manufacturer by making a cash payment to that company in the net amount of approximately $1.3 million. This transaction was completed pursuant to an amendment of our Master Supply Agreement with our contract manufacturer. In addition to the purchase of the raw materials inventory from our contract manufacturer, this amendment provided for the eventual assumption by us of full responsibility from our contract manufacturer for the manufacturing of our proprietary Energy Storage Systems (“ESS”) units. Pursuant to the amendment, we assumed such responsibility for the manufacturing process surrounding our ESS units from our contract manufacturer on June 1, 2023. In conjunction with assuming this responsibility, we hired the employees of our contract manufacturer who previously performed contract manufacturing services for us.

 

Other Developments

 

We continue to monitor current international developments occurring in Ukraine and Israel. However, we do not believe that they will have a significant impact on either the domestic markets for our products or the international supply chains for our product components, which are largely sourced from Asis.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements. See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Financial Statements set forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024, for a further description of our critical accounting policies and estimates.

 

 

 

 16 

 

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Information for this Item is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We have established and maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial and accounting officer, to allow timely decisions regarding required disclosures.

 

As of September 30, 2024, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to hire additional personnel in order to remediate our material weakness.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

Changes in Internal Controls over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the quarter ended September 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

 

 

 

 

 17 

 

 

PART II. OTHER INFORMATION

 

 

ITEM 1.LEGAL PROCEEDINGS

 

Although we may, from time to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated to be brought against us.

 

ITEM 1A.RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024 (the “Form 10-K”), under the heading “Risk Factors”, and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2024, under “Risk Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There have been no sales of unregistered securities during the three months ended September 30, 2024.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).

 

 

 

 

 18 

 

 

 

ITEM 6.EXHIBITS

 

Exhibit No.   Exhibit Description
10.1   Line of Credit Agreement between NeoVolta, Inc. and National Energy Modelers, Inc., dated September 3, 2024 (incorporated by reference to exhibit 10.1 to the Company’s Form 8-K filed September 4, 2024)
31.1*   Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *   Inline XBRL Instance Document
101.SCH *   Inline XBRL Taxonomy Extension Schema Document
101.CAL *   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

______________________

* Filed herewith.

 

 

 

 

 

 

 

 

 

 

 

 

 19 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  NEOVOLTA, INC.  
     
     
November 8, 2024 /s/ H. Ardes Johnson  
  H. Ardes Johnson  
  Chief Executive Officer  
  (Principal Executive Officer)  
     
November 8, 2024 /s/ Steve Bond  
  Steve Bond  
  Chief Financial Officer  
  (Principal Financial/Accounting Officer)  

 

 

 

 

 

 

 

 

 

 

 

 

 

 20